irinotecan has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araz, M; Kerimoglu, U; Keskin, M; Kilinc, F; Kucukkartallar, T | 1 |
| Almeida, PRC; Lima-Júnior, RCP; Malveira, LRC; Marcolino Assis-Júnior, E; Melo, AT; Moreira, LS; Oliveira, CMG; Pereira, VBM; Sousa, NRP; Souza, MHLP; Wong, DVT | 1 |
2 other study(ies) available for irinotecan and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Irinotecan-induced NASH and liver failure.
Topics: Humans; Irinotecan; Liver; Liver Failure; Non-alcoholic Fatty Liver Disease; Topoisomerase I Inhibitors | 2021 |
Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Bacterial Infections; Biomarkers; Camptothecin; Cytokines; Female; Irinotecan; Lipid Metabolism; Liver; Liver Function Tests; Mice; Neutrophil Infiltration; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Silymarin; Sulfhydryl Compounds | 2017 |